(Q50725071)

18 March 2018

title

What has computer-aided molecular design ever done for drug discovery? (English)

1 reference

18 March 2018

0 references

1 reference

David E Clark

1

1 reference

18 March 2018

language of work or name

English

0 references

publication date

1 July 2006

1 reference

18 March 2018

Expert Opinion on Drug Discovery

published in

1 reference

18 March 2018

volume

1

1 reference

18 March 2018

issue

2

1 reference

18 March 2018

page(s)

103-110

1 reference

18 March 2018

Computer-assisted drug design. Part I. Conditions in the 1980s

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17460441.1.2.103

The discovery of potent nonpeptide angiotensin II receptor antagonists: a new class of potent antihypertensives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.1.2.103

Application of the three-dimensional structures of protein target molecules in structure-based drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.1.2.103

Rational design of potent sialidase-based inhibitors of influenza virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.1.2.103

ProPose: a docking engine based on a fully configurable protein-ligand interaction model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.1.2.103

ProPose: steered virtual screening by simultaneous protein-ligand docking and ligand-ligand alignment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.1.2.103

Discovery of a novel series of DHODH inhibitors by a docking procedure and QSAR refinement

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.1.2.103

Biphenyl-4-ylcarbamoyl thiophene carboxylic acids as potent DHODH inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.1.2.103

Dual binding mode of a novel series of DHODH inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.1.2.103

Application and limitations of X-ray crystallographic data in structure-based ligand and drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.1.2.103

Enhancing the accuracy, the efficiency and the scope of free energy simulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.1.2.103

Scoring functions for protein-ligand interactions: a critical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.1.2.103

Integrating molecular design resources within modern drug discovery research: the Roche experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.1.2.103

Generation and selection of novel estrogen receptor ligands using the de novo structure-based design tool, SkelGen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.1.2.103

21 January 2018

Identifiers

DOI

10.1517/17460441.1.2.103

1 reference

18 March 2018

1 reference

18 March 2018